Conba Buys 84% of Yunnan Xiogye Pharma

Zhejiang Conba Pharma bought an 84% stake in Yunnan Xiongye Pharmaceutical Ltd., a company that makes both TCMs and western drugs. Last year, Xiongye lost 4.7 million RMB ($739,000) on 7.8 million RMB ($1.2 million) of revenue. Founded in 1969, Xiongye has a portfolio of over 40 products, the ostensible reason for Conba's interest. Terms of the transaction were not disclosed. More details.... Stock Symbol: (SHA: 600572)     Share this with colleagues:    
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.